Medicare and Medicaid Reform: Prescription Drug Coverage for Elderly
This paper examines the history, structure, and current challenges facing Medicare and Medicaid — the two primary government-sponsored health insurance programs serving elderly and disadvantaged Americans. Drawing on policy analysis and healthcare research, the paper reviews the composition of Medicare Parts A and B, the eligibility criteria for Medicaid, and the growing strain placed on both programs by an aging baby boomer population. A central focus is the absence of outpatient prescription drug coverage under Medicare, the financial burden this places on elderly enrollees, and the ongoing congressional debate over a national drug benefit plan. The paper concludes with recommendations for sustaining both programs and argues that affordable prescription drug access is the most critical element of meaningful Medicare and Medicaid reform.
- Introduction: Overview of Medicare, Medicaid, and reform rationale
- Brief History of Medicare in the United States: Medicare Parts A and B structure and origins
- Problems That Medicare Faces: Enrollment growth, restrictions, and provider withdrawal
- Medicare and the Prescription Drug Quandary: Drug coverage gap and cross-border purchasing
- Medicaid: History, Eligibility, and Role in Elderly Care: Medicaid eligibility types and benefit scope
- The Importance of Medicare and Medicaid to the Elderly Population: Combined programs' role in elderly health access
- Conclusions and Recommendations: Reform recommendations and prescription drug plan urgency
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper grounds its policy argument in concrete statistics — such as the projected 77 million Medicare enrollees by 2030 and the 90% satisfaction rate among current enrollees — giving the claims measurable support.
- It balances program strengths with genuine weaknesses, acknowledging Medicare's historical success before cataloguing its structural vulnerabilities, which adds intellectual fairness to the argument.
- The prescription drug issue is threaded throughout multiple sections rather than confined to one, demonstrating how a single policy gap has cascading effects on elderly well-being.
Key academic technique demonstrated
The paper uses a problem–context–recommendation structure common in policy analysis: it establishes what the programs are and why they matter, then identifies specific failures (especially the prescription drug gap), and closes with targeted reform recommendations. This organizational logic helps the reader follow the argument from evidence to conclusion without losing the thread.
Structure breakdown
The paper opens with a broad introduction establishing the scope and purpose of the discussion, then moves into historical background on Medicare and Medicaid in separate sections. A dedicated section addresses the prescription drug coverage gap, followed by a section on Medicaid's role for low-income elderly residents. A synthesis section underscores the combined importance of both programs before the paper closes with conclusions and policy recommendations. References follow APA-adjacent journal citation formatting.
Introduction
Medicare and Medicaid are government-sponsored programs whose objective is to provide patients with health assistance upon meeting specific criteria. Medicare is the federal program that provides insurance for elderly patients aged 65 and over, and approximately 40 million people are enrolled in this program. Medicaid is an insurance program available for disadvantaged persons, including the elderly, who cannot afford health benefits because of low incomes or other factors. Both programs are subsidized by government funds and, in many instances, will cover the costs of basic medical care as well as specialized testing and supplies.
However, as time progresses and the elderly population grows and requires additional medical care, it is evident that Medicare and Medicaid are assuming less responsibility for healthcare costs, leaving the majority of those costs to be absorbed by the patient. Furthermore, the need for prescription drugs is on the rise, yet pharmaceuticals are only covered by Medicare when they are used in a hospital setting. Congress has been in the process of developing a bill that would provide $310 billion for prescription drug coverage under Medicare over a ten-year period, with an additional $40 billion directed to hospitals and doctors to increase payments (Economist 28). However, this plan is not the complete answer to the problems Medicare faces today. Medicaid, similarly, is not a fail-safe plan in its own right.
Elderly persons are left to absorb much of the cost of their healthcare expenses in today's market, and their financial resources are increasingly strained. In order to reestablish Medicare as a dominant force in today's healthcare market, government leaders must evaluate Medicare and Medicaid in their current states and determine where reform is necessary in order to protect the financial well-being of distressed recipients. This paper presents a sustained argument for the implementation of a national prescription drug plan for elderly persons who depend on Medicare and Medicaid for their medical insurance needs. Since prescription drugs are costly and vital to the health and well-being of elderly persons, they should be the central focus of Medicare and Medicaid reform.
This issue warrants extended discussion because of its relevance to an ever-increasing elderly population in the United States. It is critical for Americans to gain awareness of government initiatives such as Medicare and Medicaid, to diagnose their problems, and to determine possible mechanisms for reform in order to maximize benefits for elderly recipients.
Works Cited
Ettner, S. "Medicaid Participation Among the Eligible Elderly." Journal of Policy Analysis and Management 16.2 (1997): 237–255.
Economist. "Say Yes to Drugs." Economist 363.8279 (2002): 28–29.
Korcok, M. "U.S. MDs Respond to Pay Cuts by Turning Backs on Medicare." Canadian Medical Association Journal 166.10 (2002): 1322.
ManagedHealthcare.Info. "High Costs Driving Elderly Across Border on Prescription Drug Runs." ManagedHealthcare.Info. 2002.
Vladeck, B. "Medicare: Can Its Benefits Be Sustained as Cost of Coverage Grows?" Geriatrics 56.5 (2001): 50–54.
Create your account
Always verify citation format against your institution’s current style guide requirements.